Coronary Flow Velocity Reserve is Improved by PPAR-α Agonist Fenofibrate in Patients with Hypertriglyceridemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Coronary Flow Velocity Reserve is Improved by PPAR-α Agonist Fenofibrate in Patients with Hypertriglyceridemia

Published:2012-01-26 Issue:3 Volume:31 Page:161-167
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:Cardiovasc Ther

Author:

Wang Guang,He Liyun,Liu Jinbo,Yu Jie,Feng Xinheng,Li Fuwang,Hao Yanting,Mao Jieming,Hong Tianpei,Chen Alex F.,Wang Xian

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5922.2011.00307.x/fullpdf

Reference30 articles.

1. Oral administration of tetrahydrobipterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice;Hattori;Arterioscler Thromb Vasc Biol,2007

2. Pleiotropic action of peroxisome proliferator-activated receptors in lipid metabolism and atheroslcerosis;Barbier;Arterioscler Thromb Vasc Biol,2002

3. Global suppression of IL-6-induced acute phase response gene expression after in vivo chronic treatment with the peroxisome proliferator-activated receptor αactivator fenofibrate;Gervois;J Biol Chem,2004

4. Effects of fenofibrate and simvastatin on plasma sICAM and MCP-1 concentrations in patients with hyperlipoproteinemia;Kowalski;Int J Clin Pharmacol Ther,2003

5. Peroxisome proliferator-activated receptor α agonists increase nitric oxide synthase expression in vascular endothelial cells;Goya;Arterioscler Thromb Vasc Biol,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Statin or Fibrate Therapy on Homocysteine Concentrations: A Systematic Review and Meta-analysis;Current Medicinal Chemistry;2024-04

2. Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review;Diabetes & Metabolism Journal;2024-03-31

3. Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease;Medicinal Research Reviews;2023-04-29

4. PPAR-α Agonist Fenofibrate Prevented Diabetic Nephropathy by Inhibiting M1 Macrophages via Improving Endothelial Cell Function in db/db Mice;Frontiers in Medicine;2021-06-29

5. Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy;Medical Hypotheses;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3